Wednesday, 5 January 2022 Reading time : 3 minutes

The favourite Swiss Stocks for 2022
The year 2021 was dominated by the economic recovery. The vaccinations against Covid 19 and the affirmation of the central banks to continue their loose monetary policy ultimately also led to a further recovery on the stock markets. Despite the catch-up, the Swiss equity market will, in our view, continue to offer attractive investment opportunities in 2022. This is because many Swiss equities have not yet made up for their "Corona dip". Other stocks that have already performed well in recent months may continue to benefit from the the possible pursuance of the economic upturn.

The new basket in detail
The ten selected shares - five large caps (Alcon, Logitech, Nestlé, Novartis and SGS) and five small and mid caps (Ascom, Helvetia, Mobilezone, SoftwareONE and Zehnder) - are included in the basket in the initial fixing period at 12.50% (large caps and Helvetia) and 6.25% (small and mid caps). In relation to the market capitalisation, small and mid-sized companies are thus weighted relatively higher in the basket. Especially in positive market phases, this results in higher earnings momentum and greater price gain potential.

One of the favourites among the large caps is Alcon, due to its transformation initiated in 2016. Logitech is benefiting from the ongoing pandemic and the trend towards home offices. Nestlé remains agile, with strong growth and margins. Novartis is characterised above all by a high and sustainable dividend yield, and SGS is the market leader in the TIC market (testing, inspection, certification). Among the small and mid caps, Ascom is benefiting from the digitalisation trends in the healthcare sector. Helvetia stands out thanks to good operational development. Mobilezone continues to drive its online expansion. SoftwareONE benefits from the digital transformation and Zehnder from energy-efficient buildings.

At the time of the issue, all stocks were rated "overweight" by ZKB Research. There are no distributions to the investor. The net dividends distributed by the underlying is reinvested into the structured product.

Performance Review
he cumulative outperformance of the ZKB Favourites after costs vs. the SPI® Index since 2015 amounts to 14.54%. Compared to 100.84% in the SPI® Index, investors could achieve a performance of 115.38% with the ZKB Favourite Stocks.

Tracker Certificate on ZKB Favourite Stocks 2022

• Diversification through combination of large, mid and small caps
• Net dividends are reinvested
• Stock selection by ZKB Research

• CHF 100 issue price
• 12 month duration
• Subscription ends 18 January 2022, 4 p.m. CET

Go to Termsheet
Go to Factsheet

Capped Outperformance Certificate on ZKB Favourite Stocks 2022

• 150% participation
• 110% cap level

• CHF 100 issue price
• 12 month duration
• Subscription ends 18 January 2022, 4 p.m. CET

Go to termsheet

All indicative data

 

Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements.
The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document.
If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.